---
title: "Research into the safety of a new agent (AX-5006) in people with and without Parkinson's disease."
euct_id: 2025-523254-14-00
phase: Phase 1
status: Recruiting
sponsor: Vertero Therapeutics Inc.
canonical_url: "https://parkinsonspathways.com/trials/eu/2025-523254-14-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2025-523254-14-00"
ctis_last_updated: "2026-03-06T02:42:29.075395126"
source: EU Clinical Trials Information System (CTIS)
---
# Research into the safety of a new agent (AX-5006) in people with and without Parkinson's disease.

**EU CT Number:** [2025-523254-14-00](https://euclinicaltrials.eu/ctis-public/view/2025-523254-14-00)

## Key Facts

- **Phase:** Phase 1
- **Status:** Recruiting
- **Sponsor:** Vertero Therapeutics Inc.
- **Start Date:** 2025-10-22
- **Completion Date:** 2026-08-01
- **Conditions:** Parkinson's disease

## Member States

Trial is authorized in 1 member state: Netherlands.

## Sites (1)

- Centre for Human Drug Research, Leiden, Netherlands

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: adults 18-64, elderly 65+
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2025-523254-14-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2025-523254-14-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2025-523254-14-00*